Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omission of sentinel lymph node biopsy among women age 50-70 with early-stage breast cancer: applying an updated ASCO Guideline to a real-world population.

Practical radiation oncology·2026
Same author

MAX-SHOCK: A Pragmatic Randomized Controlled Trial Comparing Biphasic Defibrillators Used in Routine Cardioversion of Atrial Fibrillation.

CJC open·2026
Same author

A Primer on Rare Cardiac Diseases.

The Canadian journal of cardiology·2026
Same author

Antithrombotic Therapy after Ablation for Atrial Fibrillation. Reply.

The New England journal of medicine·2026
Same author

Targeted Intra-Atrial Delivery of GMP-Grade Human Extracellular Vesicles Prevents Inflammation-Driven Postoperative Atrial Fibrillation in Pigs.

JACC. Basic to translational science·2026
Same author

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.

European journal of heart failure·2026

Related Experiment Video

Updated: Jun 24, 2025

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

961

Development of a Mouse Cardiac Sarcoidosis Model Using Carbon Nanotubes.

Sophie Van Remortel1, Yousef Risha1, Sandrine Parent1

  • 1University of Ottawa Heart Institute, Division of Cardiology, Department of Medicine, University of Ottawa, Ottawa, K1Y4W7, Canada.

Advanced Biology
|June 12, 2024
PubMed
Summary

Researchers developed a new animal model for cardiac sarcoidosis (CS) using carbon nanotubes and aortic constriction. This model shows promise for studying CS, improving diagnosis, and testing new treatments.

Keywords:
cardiac sarcoidosisfibrosisheartmouse modelsarcoidosis

More Related Videos

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.7K
Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model
09:57

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Published on: April 1, 2019

7.3K

Related Experiment Videos

Last Updated: Jun 24, 2025

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

961
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.7K
Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model
09:57

Seeding and Implantation of a Biosynthetic Tissue-engineered Tracheal Graft in a Mouse Model

Published on: April 1, 2019

7.3K

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Toxicology

Background:

  • Cardiac sarcoidosis (CS) is a severe manifestation of sarcoidosis, a granulomatous disease of unknown cause.
  • Significant morbidity and mortality are associated with CS, often presenting as conduction abnormalities and heart failure.
  • A lack of reliable animal models hinders research into CS pathogenesis and treatment development.

Purpose of the Study:

  • To develop and validate a novel, easily executable animal model for cardiac sarcoidosis (CS).
  • To investigate the effects of carbon nanotube (CNT) injection and transverse aortic constriction (TAC) on cardiac tissue and function.
  • To establish a platform for disease profiling, biomarker discovery, and therapeutic evaluation in CS.

Main Methods:

  • Intramyocardial injection of carbon nanotubes (CNTs) to induce granuloma formation.
  • Transverse aortic constriction (TAC) to prime the immune system and induce cardiac stress.
  • Combined CNT injection and TAC to assess impact on cardiac fibrosis, function, and conduction.

Main Results:

  • Intramyocardial CNT injection alone induced sarcoid-like histiocytes but had minimal impact on cardiac fibrosis or function.
  • Pre-treatment with TAC followed by CNT injection significantly enhanced cardiac fibrosis and diminished cardiac function.
  • The combined stressor model impaired cardiac conduction, mimicking key CS pathologies.

Conclusions:

  • A novel, readily implementable animal model for cardiac sarcoidosis (CS) has been successfully developed.
  • This model effectively replicates key pathological features of CS, including granuloma formation, fibrosis, impaired function, and conduction abnormalities.
  • The model serves as a valuable tool for advancing the understanding, diagnosis, and treatment of cardiac sarcoidosis.